Author: IQ TIMES MEDIA

Over the years, Fitbit has established itself as a leader in health and fitness tracking, with devices that boast reliable heart rate sensors and compact, user-friendly designs. The Versa 4 is one of the company’s pricier offerings, and it packs all of the brand’s fitness tracking perks into a sleek design that resembles a full-fledged smartwatch more than a typical Fitbit. However, despite some cool touches here and there, the device falls short of its full potential.While testing the best Fitbits over the last six months, I found the Versa 4 to be Fitbit’s most stylish wearable. It’s equipped with…

Read More

Nearly one in five patients with urinary infections in a research group likely contracted them from contaminated meat –an issue that could be occurring across the country, according to a new study. The study, published on Oct. 23 in the mBio journal, looked at a group of people in Southern California over four years. Out of the more than 2,300 urinary tract infections (UTI) sampled in the study, 18% – or more than 4,200 – were linked to the same strain of E. coli found in contaminated meat in local grocery stores.While E. coli accounts for up to 90% of…

Read More

By Sam TabahritiLONDON (Reuters) -Britain’s medicines regulator said on Friday it had made the world’s largest seizure of unlicensed weight-loss medicines, dismantling a factory that made jabs labelled as containing the ingredient in Eli Lilly’s Mounjaro.Global pharmaceutical companies and regulators have raised alarms over a surge in counterfeit and unregulated weight-loss drugs, which are being trafficked globally and sold illegally online and through underground networks.The Medicines and Healthcare products Regulatory Agency (MHRA) said it had seized 2,000 injection pens labelled as containing tirzepatide – the ingredient in Eli Lilly’s Mounjaro and Zepbound – and retatrutide, an experimental obesity drug also…

Read More

OpenAI recently launched new app integrations in ChatGPT to allow you to connect your accounts directly to ChatGPT and ask the assistant to do things for you. For instance, with a Spotify integration, you can tell it to create personalized playlists that will show up right in your Spotify app. To get started, make sure you’re logged into ChatGPT. Then type the name of the app you want to use at the start of your prompt, and ChatGPT will guide you through signing in and connecting your account. If you want to set everything up at once, head over to…

Read More

When you buy through our links, Business Insider may earn an affiliate commission. Learn moreWe take our phones everywhere, which means they’re bound to get dropped or scratched at some point. Investing in a solid case is the best way to prepare for when the inevitable happens and keep your phone looking like it just came out of the box for longer. Luckily, we’ve got you covered with the best iPhone 16 Pro cases on the market.Whether you’re a light traveler who likes their phone to double as a wallet, someone who uses MagSafe accessories, or you just want something…

Read More

While the tech and finance world continues to debate whether we’re in an AI bubble, one thing is for sure: People love AI!For proof, like no further than Apple’s App Store, where OpenAI’s ChatGPT app and its Sora video spinoff are atop the “free app” rankings, and … A screenshot of Apple’s iOS app store on October 24 shows a surprising entrant at the top of the rankings. Apple Whoops? So maybe we love AI, but we love fried chicken more?Answer: We love — or are at least interested in — both things. But the reason Dave’s Hot Chicken is…

Read More

A 13-year-old boy was hospitalized after eating dozens of high-powered magnets, according to a recently published case report in the New Zealand Medical Journal. The boy lost part of his bowel as a result, doctors wrote.The boy, who was not identified in the case report, ate between 80 and 100 magnets. The “high-power” magnets were 5×2 millimeters each, the report said.After eating the magnets, the teen had general abdominal pain for four days. When he arrived at the hospital, he told doctors he had eaten the magnets about a week earlier. The hospital he was treated at was not identified…

Read More

(Reuters) -Eli Lilly announced on Friday safety and efficacy results from two separate late-stage studies testing its approved drugs for alopecia and eczema.The company was testing baricitinib, sold under the brand name Olumiant, in 257 adolescent patients with severe alopecia areata or patchy hair loss. In the trial, a 4 milligram dose of baricitinib helped improve hair regrowth in more than 50% of adolescents after one year of treatment.Successful regrowth was also observed with a 2 milligram dose, the company said, adding that the safety profile of baricitinib remained consistent with previous reports.In another trial, Lilly was testing Ebglyss, chemically…

Read More

Before Kong CEO Augusto Marietti cofounded the API company, he was trading his pasta-cooking skills for a spot on former Uber CEO Travis Kalanick’s couch.”Travis gave me his place to stay for a few weeks as long as I would cook carbonara for his better half once a week,” Marietti told A16z general partner Martin Casado during an episode of the firm’s podcast.Marietti recounted in vivid detail how, after spending months coding in a garage in Milan, he and his cofounders spent the last money they had to fly to the US on tourist visas in a last-ditch effort to…

Read More

The browser wars are heating up again, this time with AI in the driver’s seat.  OpenAI just launched Atlas, a ChatGPT-powered browser that lets users surf the web using natural language and even includes an “agent mode” that can complete tasks autonomously. It’s one of the biggest browser launches in recent memory, but it’s debuting with an unsolved security flaw that could expose passwords, emails, and sensitive data.  On TechCrunch’s Equity podcast, Max Zeff, Anthony Ha and Sean O’Kane break down Atlas’s debut, the broader wave of alternative browsers, and more of the week’s startup and tech news.  Listen to…

Read More